Burning Rock Biotech Ltd
NASDAQ:BNR
Balance Sheet
Balance Sheet Decomposition
Burning Rock Biotech Ltd
Current Assets | 884.1m |
Cash & Short-Term Investments | 615.1m |
Receivables | 149.6m |
Other Current Assets | 119.4m |
Non-Current Assets | 155.9m |
Long-Term Investments | 337k |
PP&E | 144.2m |
Intangibles | 964k |
Other Non-Current Assets | 10.4m |
Current Liabilities | 263.4m |
Accounts Payable | 18.1m |
Accrued Liabilities | 113.6m |
Other Current Liabilities | 131.7m |
Non-Current Liabilities | 8.2m |
Other Non-Current Liabilities | 8.2m |
Balance Sheet
Burning Rock Biotech Ltd
Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash & Cash Equivalents |
93
|
94
|
1 895
|
1 431
|
906
|
615
|
|
Cash Equivalents |
93
|
94
|
1 895
|
1 431
|
906
|
615
|
|
Short-Term Investments |
43
|
317
|
367
|
66
|
2
|
0
|
|
Total Receivables |
83
|
209
|
147
|
158
|
170
|
150
|
|
Accounts Receivables |
36
|
90
|
111
|
135
|
152
|
150
|
|
Other Receivables |
47
|
119
|
36
|
23
|
19
|
0
|
|
Inventory |
49
|
58
|
68
|
123
|
130
|
69
|
|
Other Current Assets |
25
|
29
|
46
|
43
|
51
|
50
|
|
Total Current Assets |
293
|
707
|
2 524
|
1 821
|
1 259
|
884
|
|
PP&E Net |
70
|
89
|
112
|
406
|
300
|
144
|
|
PP&E Gross |
70
|
89
|
112
|
406
|
300
|
0
|
|
Accumulated Depreciation |
64
|
93
|
119
|
161
|
277
|
0
|
|
Intangible Assets |
1
|
0
|
4
|
5
|
2
|
1
|
|
Note Receivable |
0
|
0
|
0
|
0
|
5
|
5
|
|
Long-Term Investments |
2
|
40
|
1
|
1
|
1
|
0
|
|
Other Long-Term Assets |
8
|
11
|
23
|
45
|
21
|
5
|
|
Total Assets |
373
N/A
|
848
+127%
|
2 663
+214%
|
2 279
-14%
|
1 588
-30%
|
1 040
-34%
|
|
Liabilities | |||||||
Accounts Payable |
16
|
12
|
36
|
63
|
51
|
18
|
|
Accrued Liabilities |
25
|
51
|
79
|
150
|
192
|
114
|
|
Short-Term Debt |
136
|
2
|
7
|
2
|
0
|
0
|
|
Current Portion of Long-Term Debt |
43
|
42
|
40
|
0
|
0
|
0
|
|
Other Current Liabilities |
64
|
57
|
80
|
157
|
169
|
132
|
|
Total Current Liabilities |
285
|
164
|
242
|
372
|
412
|
263
|
|
Long-Term Debt |
93
|
23
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
2
|
25
|
1
|
61
|
18
|
8
|
|
Total Liabilities |
380
N/A
|
212
-44%
|
242
+14%
|
433
+79%
|
429
-1%
|
272
-37%
|
|
Equity | |||||||
Common Stock |
596
|
1 527
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
612
|
947
|
1 418
|
2 229
|
3 200
|
3 854
|
|
Additional Paid In Capital |
23
|
46
|
4 007
|
4 281
|
4 583
|
4 849
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
59
|
66
|
|
Other Equity |
15
|
9
|
168
|
207
|
166
|
162
|
|
Total Equity |
7
N/A
|
636
N/A
|
2 421
+281%
|
1 845
-24%
|
1 158
-37%
|
768
-34%
|
|
Total Liabilities & Equity |
373
N/A
|
848
+127%
|
2 663
+214%
|
2 279
-14%
|
1 588
-30%
|
1 040
-34%
|
|
Shares Outstanding | |||||||
Common Shares Outstanding |
102
|
102
|
105
|
105
|
105
|
103
|